Discordance of PD-L1 Expression at the Protein and RNA Levels in Early Breast Cancer

SIMPLE SUMMARY: Despite the increasing use of checkpoint inhibitors for early and metastatic breast cancer, Programmed Death Ligand 1 (PD-L1) remains the only validated albeit imperfect predictive biomarker. Significant discordance in PD-L1 protein expression depending on the antibody used has been...

Descripción completa

Detalles Bibliográficos
Autores principales: Zerdes, Ioannis, Karafousia, Vaia, Mezheyeuski, Artur, Stogiannitsi, Maria, Kuiper, Raoul, Moreno Ruiz, Pablo, Rassidakis, George, Bergh, Jonas, Hatschek, Thomas, Foukakis, Theodoros, Matikas, Alexios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467035/
https://www.ncbi.nlm.nih.gov/pubmed/34572882
http://dx.doi.org/10.3390/cancers13184655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467035/
https://www.ncbi.nlm.nih.gov/pubmed/34572882
http://dx.doi.org/10.3390/cancers13184655

Ejemplares similares